Introduction
============

The actual pathogenic event initiating arthritis is largely unknown. For several forms of arthritis, an infectious etiology has been postulated \[[@B1]-[@B3]\]. In particular, reactive arthritis (ReA) is known to be triggered by a variety of bacteria. For *Salmonella*, *Yersinia*, and *Chlamydia*, a persistent infection has been hypothesized due to the intraarticular presence of bacterial antigens, DNA, and/or RNA \[[@B4]-[@B6]\]. There is also evidence that undifferentiated arthritis is a form of ReA (\'forme fruste\') possibly due to a preceding but asymptomatic infection \[[@B7],[@B8]\]. PCR using universal 16S rRNA primers is a highly sensitive tool allowing detection of unknown, that is unsuspected, pathogens relating to all eubacterial species \[[@B9]-[@B11]\]. This tool has been used before in patients with ReA, undifferentiated arthritis (UA), and other arthropathies. However, in most studies, the PCR products were of sufficient length to determine the genus of the bacteria in the synovial samples, but were not long enough to identify the species level \[[@B12]-[@B14]\].

We previously used the broad-range PCR, cloning and sequencing the entire 16S rDNA and demonstrated the presence of a large number of bacterial DNA in the synovial tissue (ST) of patients with ReA, UA, and other arthropathies \[[@B15]\]. These bacterial DNA were mainly derived from commensals that are normally present in the skin and gut. We also detected DNA of specific bacterial groups that have not been detected in arthritis samples or in human infections so far, suggesting that these new bacteria possibly could have a pathogenic relevance, particularly with regard to the ST. The detection of such a variety of bacterial groups after cloning and near full-length 16S rDNA sequencing obtained in ST samples has raised the question if the identical bacterial DNA communities could reside in both the ST and the synovial fluid (SF) of matched arthritis patients \[[@B15]\]. In addition, the composition of bacterial DNA from ST samples has not been compared comprehensively with that of matched SF samples in arthritis patients. Besides, a detailed analysis of SF bacterial DNA and their comparison with those from corresponding ST samples might help to determine whether intraarticular bacterial DNA might change over time between the two synovial compartments.

As opposed to SF \[[@B12],[@B16]\], the bacterial DNA communities in the ST are well documented \[[@B13],[@B14],[@B17]-[@B19]\] and to our knowledge, there is no study that has amplified the entire 16S rDNA from SF samples.

Accordingly, we now continue our study using PCR as well as cloning and sequencing of the entire 16S rDNA to identify any bacterial DNA potentially present in the SF samples of patients with ReA, UA, and other forms of arthritis who were also analyzed previously \[[@B15]\].

Materials and methods
=====================

Patients and synovial fluid samples
-----------------------------------

Twenty-seven patients with active arthritis and knee effusion gave informed consent and were included in the study, which was approved by the local ethical committees. ST samples of these patients were used in a previous study \[[@B15]\]. The clinical characteristics as well as technical aspects regarding prevention of contamination during sampling have recently been published in detail \[[@B15]\].

Among the 27 patients included in the study, five were diagnosed with ReA, and nine with undifferentiated arthritis (UA); we also included seven patients with rheumatoid arthritis (RA) and six with osteoarthritis (OA) who served as controls. In the current study, the 27 patients were identical to the 27 patients analyzed in our previously published study (from patient 2 to patient 28) \[[@B15]\]. The clinical features and demographic characteristics of the patients are summarized in Table [1](#T1){ref-type="table"}. SF samples were aspirated by standard needle puncture, snap frozen in liquid nitrogen, and stored at -80°C until analysis.

###### 

Demographic and clinical features of the study patients

  Diagnosis (patients; n = 27)   Median disease duration, months (range)   Actual age or median age, years (range)   Sex ratio (M/F)   Clinical details
  ------------------------------ ----------------------------------------- ----------------------------------------- ----------------- --------------------------------------------------------------------------------------------
  ReA (n = 5)                    2.4 (1 to 6)                              32.4 (20 to 50)                           4:1               
   1                                                                       22                                        M                 Sexually acquired ReA; *Ct*IgG positive^a^, *Ct*IgA positive serology^b^
   2                                                                       40                                        F                 Sexually acquired ReA;
   3                                                                       20                                        M                 Sexually acquired ReA; *Ct*IgG positive serology^a^; *Ct*IgA positive serology^b^; B27+^d^
   4                                                                       50                                        M                 Sexually acquired ReA; *Ct*IgA positive serology^b^; *Ct*positive PCR^c^; B27+^d^
   5                                                                       30                                        M                 Sexually acquired ReA
  UA (n = 9)                     25 (2 to 60)                              40 (22 to 59)                             5:4               \-
  RA (n = 7)                     66 (12 to 228)                            44 (39 to 53)                             2:5               \-
  OA (n = 6)                     14 (12 to 24)                             58 (44 to 70)                             5:1               \-

^a^Serology was determined for *Ct*-IgG antibodies by Micro Immunofluorescence assay as described by Wang and Grayston \[[@B29]\]. ^b^Serology was determined for *Ct*-IgA antibodies by ELISA (Labsystems, Hilsinki, Finland). ^c^*Chlamydia*PCR in genital swabs was determined by Cobas Amplicor PCR assay (Roche Diagnostics Molecular Systems, Inc, CA, USA). ^d^HLA-B27 positivity was determined using a microcytotoxicity assay.

*Ct*= *Chlamydia trachomatis*; RA = rheumatoid arthritis; ReA = reactive arthritis; OA = osteoarthritis; UA = undifferentiated arthritis.

Automated DNA extraction from synovial fluid and broad-range PCR amplification of 16S rRNA genes, cloning and sequencing of bacterial DNA
-----------------------------------------------------------------------------------------------------------------------------------------

For 10 minutes, 500 μl of SF were centrifuged at 10,000 g. The whole SF cell pellet was subjected to DNA extraction using the MagNA Pure system (Roche Molecular Biochemicals, Meylan, France). Prior to the MagNA Pure extraction, 500 μl of lysis buffer (200 mM sodium chloride, 20 mM Tris hydrochloric acid, pH 8, 50 mM ethylenediaminetetraacetic acid and 1% SDS) and 25 μl of proteinase K (10 mg/ml) (Sigma, St Louis, MO, USA) were added to the SF cell pellet.

Bacterial 16S rDNA fragments were amplified from SF extracted DNA by broad-range PCR amplification using universal bacterial 16S rRNA gene-specific oligonucleotide primers Bac08 and Uni1390, as previously described \[[@B15]\]. Products of the expected size (approximately 1400 bp) were inserted into a vector using a cloning kit (pGEM-T vector; Promega, Madison, WI, USA). Sequencing and 16S rDNA analysis were performed as previously described \[[@B15]\].

Data analysis
-------------

Statistical analysis was performed using SPSS 11.0 software (SPSS; Chicago, IL, USA). A *P*\< 0.05 was considered statistically significant.

Results
=======

PCR positivity by the broad-range PCR amplification system
----------------------------------------------------------

PCR was positive in 20 of the 27 (74.10%) patients indicating the presence of bacterial 16S rDNA within the synovial samples. Of note, PCR was positive in five out of five (100%) patients with ReA and also in nine out of nine (100%) patients with UA. In the control group, bacterial 16S rDNA was amplified in three out of seven (43%) RA patients and in three of six (50%) OA patients. Accordingly, the presence of bacterial DNA within the SF samples was significantly higher in ReA and UA patients as compared with RA and OA patients (14 out of 14 (100%) vs 6 of 13 (46.2%); *P*= 0.006).

At least 24 individual clones were selected from each PCR product and sequenced. A summary of the total number of sequences analyzed in each patient is depicted in Table [2](#T2){ref-type="table"}. Only full-length (1300 to 1400 bp) sequences of high quality were analyzed in detail. Most bacterial sequences had at least 97% sequence similarity with any known cultivated or uncultured bacteria. The percentage of similarity to the best fit sequence in the database, the accession number, and the sequence length of each probe are listed in Table [3](#T3){ref-type="table"}.

###### 

Details of bacterial species-derived DNA sequences identified in each patient\*

  Patient   Total number of bacterial DNA sequences   DNA sequences identified in each patient
  --------- ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ReA                                                 
   1        45                                        *10 × Stenotrophomonas maltophilia*, 7 × *Shigella*species, 6 × *Propionibacterium acnes*, 3 × *Ralstonia*species, 3 × *Shigella sonnei*, 3 × uncultured bacterium, 2 × *Bradyrhizobium elkanii*, 1 × uncultured γ proteobacterium, 1 × uncultured γ proteobacterium, 2 × uncultured *Sphingobacterium*species, 1 × *Aranicola*species, 1 × *Agrobacterium*species, 1 × *Burkholderia*species, 1 × *Escherichia coli*, 1 × *Paenibacillus humicus*, 1 × *Pantoea ananatis*, 1 × uncultured β proteobacterium.
   2        47                                        13 × *Stenotrophomonas maltophilia*, 4× *Shigella*species, 3 × *Aranicola*species, 3 × *Ralstonia*species, 2 × β proteobacterium, 2 × γ proteobacterium, 2 × uncultured β proteobacterium, 1 × *Agrobacterium*species,, 1 × Bacteroidetes bacterium, 1 × *Escherichia coli*, 1 × *Escherichia*species, 1 × *Flavobacterium mizutaii*, 1 × *Pantoea ananatis*, 1 × *Paenibacillus humicus*, 1 × *Paenibacillus*species, 1 × *Propionibacterium acnes*, 3 × *Shigella sonnei*1 × *Streptococcus mitis*, 1 × swine manure bacterium, 1 × uncultured α proteobacterium, 1 × uncultured Bacteroidetes bacterium, 1 × uncultured *Flavobacterium*species, 1 × uncultured soil bacterium.
   3        42                                        10 × *Shigella*species, 9 × *Stenotrophomonas maltophilia*, 3 × *Aranicola*species, 3 × uncultured bacterium,, 2 × *Escherichia*species, 2 × *Paenibacillus humicus*, 2 × *Streptococcus mitis*, 1 × *Achromobacter xylosoxidans*, 1 × *Bradyrhizobium elkanii*, 1 × Bacteroidetes bacterium, 1 × *Flavobacterium mizutaii*, 1 × γ proteobacterium, 1 × *Propionibacterium acnes*, 1 × *Shigella sonnei*, 1 × *Streptococcus mitis*, 1 × uncultured *Flavobacterium*species, 1 × uncultured *Methylococcaceae bacterium*, 1 × uncultured Bacteroidetes bacterium
   4        49                                        *11 × Stenotrophomonas maltophilia*, 6 × γ proteobacterium, 5 × *Shigella*species, 5 × *Shigella sonnei*, 3 × *Aranicola*species, 3 × *Comamonas testosteroni*, 3 × uncultured bacterium, 2 × *Escherichia*species, 2× *Propionibacterium acnes*, 2 × uncultured *Flavobacterium*species, 2 × uncultured β proteobacterium, 1 × *Alcaligenes faecalis*, 1 × *Flavobacterium mizutaii*, 1 × *Paenibacillus humicus*1 × *Pelomonas saccharophila*, 1 × *Pseudomonas*species.
   5        31                                        5 × *Escherichia coli*, 4 × *Stenotrophomonas maltophilia*, 3 × *Escherichia coli*, 2 × *Pseudomonas*species, 2 × *Shigella*species, 2 × *Sphingomonas faeni*, 1 × *Alcaligenes faecalis*, 1 × β proteobacterium, 1 × *Comamonas testosteroni*, 1 × *Diaphorobacter*species, 1 *× Delftia acidovorans*, 1 *×Flavobacterium mizutaii*, 1 × γ proteobacterium, 1 × uncultured bacterium, 1 × uncultured β proteobacterium, 1 × *Pantoea ananatis*, 1 × *Propionibacterium acnes*, 1 × *Ralstonia*species, 1 × *Shigella sonnei*,
  UA                                                  
   6        47                                        13 × *Stenotrophomonas maltophilia*, 9 × *Shigella*species, 7 × γ proteobacterium, 2 × uncultured bacterium, 2 × uncultured *Veillonella*species, 1 × *Alcaligenes faecalis*, 1× *Agrobacterium*species, 1 × *Escherichia*species, 1 × *Streptococcus thermophilus*, 1 × *Flavobacterium mizutaii*, 1 × *Propionibacterium acnes*, 1 × uncultured β proteobacterium, 1 × uncultured bacterium, 1 × uncultured candidate division OP10 bacterium, 1 × *Pantoea ananatis*, 1 × *Shigella sonnei*, 1 × unidentiefied bacterium, 1 × uncultured *Flavobacterium*species, 1 × uncultured *Sphingobacterium*species.
   7        30                                        8 × *Stenotrophomonas maltophilia*, 3 × *Shigella*species, 2 × *Comamonas testosteroni*, 2 × *Paenibacillus humicus*, 2 × *Ralstonia*species, 2 × uncultured bacterium, 2 × uncultured β proteobacterium, 2 × uncultured *Flavobacterium*species, 1 × *Burkholderia*species, 1 × *Bradyrhizobium elkanii*, 1 × Bacteroidetes bacterium, 1 × *Escherichia coli*, 1 × *Flavobacterium mizutaii*, 1 × γ proteobacterium, 1 × *Shigella sonnei*
   8        43                                        *15 × Stenotrophomonas maltophilia*, 5 × *Shigella*species, 3 × *Escherichia*species, 3 × *Paenibacillus humicus*, 2 × uncultured bacterium, 2 × uncultured β proteobacterium, 1 × *Alcaligenes faecalis*, 1 × *Aranicola*species, 1 × *Bradyrhizobium elkanii*, 1 × *Flavobacterium mizutaii*, 1 × γ proteobacterium, 1 × *Ralstonia*species, 1 × *Staphylococcus pasteuri*, 1 × *Streptococcus mitis*, 1 × *Streptococcus pneumoniae*, 1 × *Streptococcus*species, 1 × uncultured candidate division OP10 bacterium, 1 × uncultured *Streptococcus*species, 1 × uncultured *Veillonella*species.
   9        38                                        11 × *Aquabacterium commune*, 8 × *Shigella*species, 3 × *Aranicola*species, 3 × *Paenibacillus humicus*, 2 × *Alcaligenes faecalis*, 2 uncultured bacterium, 1 × β proteobacterium, 1 × *Comamonas testosteroni*, 1× *Escherichia*species, 1 × *Kocuria*species, 1 × *Pseudomonas*species, 1 × *Paracoccus*species, 1 × *Streptococcus thermophilus*, 1 × *Streptococcus*species, 1 × uncultured β proteobacterium
   10       41                                        *13 × Stenotrophomonas maltophilia*, 4 × *Shigella*species, 3 × γ proteobacterium, 3 × *Shigella sonnei*, 1 × *Aranicola*species, 1 × *Alcaligenes faecalis*, 1× *Aeromonas*species, 1× *Burkholderia*species, 1 × *Bradyrhizobium elkanii*, 1 × *Comamonas testosteroni*, 1 × *Capnocytophaga sputigena*1 × *Enterococcus faecium*, 1× *Escherichia*species, 1 × *Enterobacter hormaechei*, 1 × *Pseudomonas poae*, 1 × *Pantoea ananatis*, 1 × *Paenibacillus humicus*, 1 × *Rhodococcus*species, 1 × *Ralstonia*species, 1 uncultured bacterium, 1 × uncultured γ proteobacterium, 1 × uncultured *Flavobacterium*species.
   11       36                                        6 × *Stenotrophomonas maltophilia*, 5 × *Shigella*species, 4 × γ proteobacterium, 4 × *Ralstonia*species, 3 × *Escherichia coli*, 2 × *Bradyrhizobium elkanii*, 2 × *Comamonas testosteroni*, 2 × uncultured bacterium, 1 × *Achromobacter xylosoxidans*, 1 × *Alcaligenes faecalis*, 1 × Bacteroidetes bacterium, 1 × *Flavobacterium mizutaii*, 1 × *Rhizobium radiobacter*, 1 × *Rhodococcus*species, 1 × uncultured β proteobacterium, 1 × uncultured organism.
   12       22                                        4 × *Shigella*species, 4 × *Stenotrophomonas maltophilia*, 3 × *Alcaligenes faecalis*, 2 × *Shigella sonnei*, 2 × uncultured β proteobacterium, 2 × uncultured bacterium, 1 × *Aminobacter aminovorans*, 1 × *Achromobacter xylosoxidans*, 1 × *Paenibacillus humicus*, 1 × *Ralstonia*species, 1 × uncultured organism.
   13       37                                        12 × *Stenotrophomonas maltophilia*, 3 × *Shigella*species, 3 × uncultured bacterium, 2 × *Bacillus niacini*, 2 × *Ralstonia*species, 1 × β proteobacterium, 1 × *Bradyrhizobium japonicum*, 1 × *Burkholderia cepacia*, 1 × *Corynebacterium durum*, 1 × *Comamonas testosteroni*, 1 × *Flavobacterium mizutaii*, 1 × γ proteobacterium, 1 × uncultured β proteobacterium, 1 × uncultured *Sphingobacterium*species, 1 × *Mycobacterium aubagnense*, 1 × *Shigella sonnei*., 1 × *Sphingomonas*species, 1 × *Sphingomonas*species, 1 × *Pseudomonas poae*, 1 × *Pantoea ananatis*.
   14       36                                        *10 × Stenotrophomonas maltophilia*, 7 × *Ralstonia*species, 3 × *Comamonas testosteroni*, 3 × uncultured bacterium, 2 × γ proteobacterium, 1 × *Escherichia*species, 1 × *Flavobacterium mizutaii*, 1 × *Methylomicrobium*species, 1 × *Paenibacillus humicus*, 1 × *Pantoea ananatis*, 1 × *Photorhabdus luminescens*, 1 × *Streptococcus pneumoniae*, 1 × uncultured *Sphingobacterium*species, 1 × uncultured *Flavobacterium*species, 1 × uncultured β proteobacterium, 1 × uncultured Firmicutes bacterium.
  RA                                                  
   15       24                                        10 × *Stenotrophomonas maltophilia*, 3 × uncultured *Flavobacterium*species, 2 × *Comamonas testosteroni*, 2 × uncultured bacterium, 1 × *Aranicola*species, 1 × *Flavobacterium mizutaii*, 1 × *Paenibacillus humicus*, 1 × *Shigella*species, 1 × *Staphylococcus cohnii*, 1 × *Sphingobacterium thalpophilum*, 1 × uncultured *Sphingobacterium*species.
   16       13                                        5 × uncultured β proteobacterium, 4 × uncultured *Flavobacterium*species, 2 × uncultured *Sphingobacterium*species, 1 × *Comamonas testosterone*, 1 × uncultured bacterium.
   17       8                                         3 × *Escherichia*species, 2 × uncultured bacterium, 1 × *Alcaligenes faecalis*, 1 × *Comamonas testosteroni*, 1 × *Shigella*species.
  OA                                                  
   18       18                                        4 × *Stenotrophomonas maltophilia*, 4 × *Shigella*species, 2 × *Flavobacterium mizutaii*, 2 × uncultured *Flavobacterium*species, 2 × uncultured *Sphingobacterium*species, 1 × *Acinetobacter junii*, 1 × *Escherichia coli O157*, 2 × uncultured bacterium.
   19       16                                        5 × *Stenotrophomonas maltophilia*, 3 × *Shigella*species, 3 × uncultured bacterium, 1 × *Alcaligenes faecalis*, 1 × *Comamonas testosteroni*, 1 × *Flavobacterium mizutaii*, 1 × *Paenibacillus humicus*, 1 × *Ralstonia*species.
   20       17                                        4 × *Stenotrophomonas maltophilia*, 3 × *Shigella*species, 3 × uncultured bacterium, 1 × *Achromobacter xylosoxidans*, 1 × *Alcaligenes faecalis*, 1 × *Bacillus cereus*, 1 × *Escherichia*species, 1 × *Rothia mucilaginosa*, 2 × uncultured β proteobacterium

OA = osteoarthritis; RA = rheumatoid arthritis; ReA = reactive arthritis; UA = undifferentiated arthritis.

###### 

Bacterial species identified by sequencing of cloned 16S rDNA

  Bacterium-derived DNA identified in SF samples                                      Number of patients in whom bacterial DNAs were detected   Accession number^a^              Length of the sequence^b^   \% Similarity^c^
  ----------------------------------------------------------------------------------- --------------------------------------------------------- -------------------------------- --------------------------- ------------------
  **Bacteria identified in ReA and UA patients (n = 69)**                                                                                                                                                    
  **Bacteria previously detected in arthritis**                                                                                                                                                              
  *Aeromonas*species                                                                  (1 UA)                                                    \[EMBL:[AF099027](AF099027)\]    1400                        97.77
  ***Burkholderia***species                                                           (1 ReA + 1 UA)                                            \[EMBL:[AY769903](AY769903)\]    1391                        99.13
  ***Burkholderia***species                                                           (1 UA)                                                    \[EMBL:[AY134849](AY134849)\]    1388                        99.71
  ***Burkholderia cepacia***                                                          (1 UA)                                                    \[EMBL:[AY946010](AY946010)\]    1390                        99.89
  *Escherichia coli*                                                                  (1 ReA)                                                   \[EMBL:[CP000243](CP000243)\]    1400                        99.14
  *Escherichia coli*                                                                  (2 ReA)                                                   \[EMBL:[U00096](U00096)\]        1400                        100.00
  *Escherichia coli*                                                                  (1 ReA + 2 UA)                                            \[EMBL:[V00348](V00348)\]        1400                        99.50
  ***Methylomicrobium***species                                                       (1 UA)                                                    \[EMBL:[AF194538](AF194538)\]    1380                        98.83
  *Propionibacterium acnes*                                                           (5 ReA + 1 UA)                                            \[EMBL:[AB108477](AB108477)\]    1386                        99.05
  *Pseudomonas*species                                                                (1 ReA)                                                   \[EMBL:[DQ213044](DQ213044)\]    1386                        99.06
  *Pseudomonas*species                                                                (1 ReA)                                                   \[EMBL:[AY014811](AY014811)\]    1395                        99.06
  *Pseudomonas*species                                                                (1 UA)                                                    \[EMBL:[AM409368](AM409368)\]    1396                        99.21
  *Paracoccus*species                                                                 (1 UA)                                                    \[EMBL:[AY745834](AY745834)\]    1320                        98.92
  *Rhodococcus*species                                                                (2 UA)                                                    \[EMBL:[AF420412](AF420412)\]    1374                        97.29
  *Shigella sonnei*                                                                   (5 ReA + 5 UA)                                            \[EMBL:[CP000038](CP000038)\]    1400                        99.71
  *Shigella sonnei*                                                                   (1 UA)                                                    \[EMBL:[X96964](X96964)\]        1389                        99.78
  *Sphingomonas*species                                                               (1 UA)                                                    \[EMBL:[AB110635](AB110635)\]    1341                        99.85
  *Sphingomonas*species                                                               (1 UA)                                                    \[EMBL:[AF385529](AF385529)\]    1341                        100.00
  *Streptococcus*species                                                              (1 UA)                                                    \[EMBL:[AF316593](AF316593)\]    1400                        98.55
  *Streptococcus*species                                                              (1 UA)                                                    \[EMBL:[AF385523](AF385523)\]    1400                        99.28
  *Streptococcus mitis*                                                               (1 ReA)                                                   \[EMBL:[AJ295848](AJ295848)\]    1400                        97.92
  *Streptococcus mitis*                                                               (1 ReA)                                                   \[EMBL:[AJ617805](AJ617805)\]    1322                        98.71
  *Streptococcus mitis*                                                               (1 ReA)                                                   \[EMBL:[AF003929](AF003929)\]    1396                        99.36
  *Streptococcus mitis*                                                               (1 ReA + 1 UA)                                            \[EMBL:[AY518677](AY518677)\]    1404                        99.86
  *Streptococcus pneumoniae*                                                          (2 UA)                                                    \[EMBL:[AM157442](AM157442)\]    1400                        98.64
  *Streptococcus thermophilus*                                                        (2 UA)                                                    \[EMBL:[AY188354](AY188354)\]    1397                        99.57
  **Bacteria not previously detected in arthritis but detected in human infection**                                                                                                                          
  ***Agrobacterium***species                                                          (2 ReA + 1 UA)                                            \[EMBL:[AY775177](AY775177)\]    1344                        99.40
  *Bradyrhizobium elkanii*                                                            (2 ReA + 4 UA)                                            \[EMBL:[AY904749](AY904749)\]    1347                        99.40
  ***Capnocytophaga sputigena***                                                      (1 UA)                                                    \[EMBL:[AF133536](AF133536)\]    1378                        98.96
  *Corynebacterium durum*                                                             (1 UA)                                                    \[EMBL:[AF537593](AF537593)\]    1391                        99.58
  ***Delftia acidovorans***                                                           (1 ReA)                                                   \[EMBL:[AB020186](AB020186)\]    1309                        97.63
  *Enterococcus faecium*                                                              (1 UA)                                                    \[EMBL:[EF533988](EF533988)\]    1396                        99.42
  *Enterobacter hormaechei*                                                           (1 UA)                                                    \[EMBL:[AY995561](AY995561)\]    1400                        99.70
  ***Kocuria***species                                                                (1 UA)                                                    \[EMBL:[AY864652](AY864652)\]    1387                        99.85
  ***Mycobacterium aubagnense***                                                      (1 UA)                                                    \[EMBL:[AY859683](AY859683)\]    1372                        99.27
  ***Pantoea ananatis***                                                              (3 ReA + 4 UA)                                            \[EMBL:[DQ133546](DQ133546)\]    1400                        98.80
  ***Photorhabdus luminescens***                                                      (1 UA)                                                    \[EMBL:[AY444555](AY444555)\]    1333                        99.85
  *Pseudomonas poae*                                                                  (2 UA)                                                    \[EMBL:[AJ492829](AJ492829)\]    1386                        98.99
  ***Rhizobium radiobacter***                                                         (1 UA)                                                    \[EMBL:[AJ389902](AJ389902)\]    1300                        99.67
  ***Staphylococcus pasteuri***                                                       (1 UA)                                                    \[EMBL:[AJ717376](AJ717376)\]    1411                        99.86
  **Bacteria not previously detected in humans**                                                                                                                                                             
  *Aquabacterium commune*                                                             (1 UA)                                                    \[EMBL:[AF035054](AF035054)\]    1416                        99.70
  ***Aminobacter aminovorans***                                                       (1 UA)                                                    \[EMBL:[AJ011759](AJ011759)\]    1344                        98.72
  ***Bacillus niacini***                                                              (1 UA)                                                    \[EMBL:[AB021194](AB021194)\]    1400                        99.14
  *Bradyrhizobium japonicum*                                                          (1 UA)                                                    \[EMBL:[AB072418](AB072418)\]    1200                        97.81
  ***Diaphorobacter***species                                                         (1 ReA)                                                   \[EMBL:[DQ294626](DQ294626)\]    1387                        99.78
  ***Pelomonas saccharophila***                                                       (1 ReA)                                                   \[EMBL:[AB021407](AB021407)\]    1381                        99.42
  ***Paenibacillus***species                                                          (1 ReA)                                                   \[EMBL:[AM162345](AM162345)\]    1385                        99.35
  ***Sphingomonas faeni***                                                            (1 ReA)                                                   \[EMBL:[AJ429239](AJ429239)\]    1340                        97.82
  **Uncultured bacteria**                                                                                                                                                                                    
  Bacteroidetes bacterium                                                             (2 UA + 1 ReA)                                            \[EMBL:[AY395022](AY395022)\]    1394                        96.11\*
  Bacteroidetes bacterium                                                             (1 ReA)                                                   \[EMBL:[DQ195837](DQ195837)\]    1300                        98.39
  β Proteobacterium                                                                   (2 ReA + 2 UA)                                            \[EMBL:[AY162033](AY162033)\]    1396                        99.57
  γ Proteobacterium                                                                   (4 ReA + 6 UA)                                            \[EMBL:[AY162042](AY162042)\]    1399                        99.00
  γ Proteobacterium                                                                   (1 ReA + 4 UA)                                            \[EMBL:[AY162068](AY162068)\]    1400                        99.50
  swine manure bacterium                                                              (1 ReA)                                                   \[EMBL:[AY167969](AY167969) \]   1395                        99.21
  Uncultured α proteobacterium                                                        (1 ReA)                                                   \[EMBL:[AF445680](AF445680)\]    1342                        97.00
  Uncultured Bacteroidetes bacterium                                                  (2 ReA)                                                   \[EMBL:[AY921801](AY921801)\]    1384                        97.04
  Uncultured bacterium                                                                (2 UA)                                                    \[EMBL:[AY958813](AY958813)\]    1388                        99.88
  Uncultured β proteobacterium                                                        (1 ReA + 1 UA)                                            \[EMBL:[AF445700](AF445700)\]    1372                        99.78
  Uncultured β proteobacterium                                                        (1 UA)                                                    \[EMBL:[DQ316806](DQ316806)\]    1391                        97.46
  Uncultured candidate division OP10 bacterium                                        (2 UA)                                                    \[EMBL:[AF418946](AF418946)\]    1362                        90.29\*
  Uncultured Firmicutes bacterium                                                     (1 UA)                                                    \[EMBL:[EF071401](EF071401)\]    1400                        99.57
  Uncultured γ Proteobacterium                                                        (1 UA)                                                    \[EMBL:[AF324537](AF324537)\]    1396                        99.96
  Uncultured γ Proteobacterium                                                        (1 ReA)                                                   \[EMBL:[AJ318146](AJ318146)\]    1400                        97.63
  Uncultured γ Proteobacterium                                                        (1 ReA)                                                   \[EMBL:[AY770720](AY770720)\]    1393                        96.91\*
  Uncultured Methylococcaceae bacterium                                               (1 ReA)                                                   \[EMBL:[EF019533](EF019533)\]    1398                        97.55
  Uncultured organism                                                                 (2 UA)                                                    \[EMBL:[DQ395839](DQ395839)\]    1392                        99.85
  Uncultured soil bacterium                                                           (1 ReA)                                                   \[EMBL:[DQ297948](DQ297948)\]    1340                        99.85
  Uncultured *Streptococcus*species                                                   (1 UA)                                                    \[EMBL:[AY256519](AY256519)\]    1400                        99.21
  Uncultured *Veillonella*species                                                     (2 UA)                                                    \[EMBL:[AM157449](AM157449)\]    1400                        99.37
  **Bacteria identified in control group (RA and OA patients; n = 10)**                                                                                                                                      
  **Bacteria previously detected in arthritis (in joint)**                                                                                                                                                   
  ***Acinetobacter junii***                                                           (1 OA)                                                    \[EMBL:[AB101444](AB101444)\]    1387                        99.28
  ***Bacillus cereus***                                                               (1 OA)                                                    \[EMBL:[AB247137](AB247137)\]    1399                        98.36
  ***Rothia mucilaginosa***                                                           (1 OA)                                                    \[EMBL:[DQ409140](DQ409140)\]    1375                        98.69
  ***Staphylococcus cohnii***                                                         (1 RA)                                                    \[EMBL:[AJ717378](AJ717378)\]    1399                        99.57
  **Bacteria not previously detected in arthritis but detected in human infection**                                                                                                                          
  ***Escherichia coli O157***                                                         (1 OA)                                                    \[EMBL:[AE005174](AE005174)\]    1394                        97.56
  **Bacteria not previously detected in humans**                                                                                                                                                             
  ***Sphingobacterium thalpophilum***                                                 (1 RA)                                                    \[EMBL:[AJ43817](AJ43817)\]      1388                        94.02\*
  **Uncultured bacteria**                                                                                                                                                                                    
  Uncultured bacterium                                                                (1 OA)                                                    \[EMBL:[DQ800655](DQ800655)\]    1394                        97.99
  Uncultured bacterium                                                                (1 RA)                                                    \[EMBL:[AY958855](AY958855)\]    1388                        99.78
  Uncultured bacterium                                                                (1 RA)                                                    \[EMBL:[AY958896](AY958896)\]    1380                        99.57
  Uncultured bacterium                                                                (1 RA + 1 OA)                                             \[EMBL:[DQ818800](DQ818800)\]    1398                        99.57
  **Common bacteria^d^(n = 20)**                                                                                                                                                                             
  **Bacteria previously detected in arthritis**                                                                                                                                                              
  *Achromobacter xylosoxidans*                                                        (1 ReA + 2 UA+ 1 OA)                                      \[EMBL:[AF439314](AF439314)\]    1389                        99.50
  *Alcaligenes faecalis*                                                              (2 ReA + 6 UA + 2 OA + 1 RA)                              \[EMBL:[AY548384](AY548384)\]    1395                        99.70
  *Comamonas testosterone*                                                            (1 ReA + 4 UA +1 OA + 3 RA)                               \[EMBL:[AB007996](AB007996)\]    1390                        99.35
  *Comamonas testosterone*                                                            (2 ReA + 3 UA + 1 OA)                                     \[EMBL:[M11224](M11224)\]        1390                        98.05
  *Escherichia*species                                                                (3 ReA + 5 UA + 1 OA + 1 RA)                              \[EMBL:[DQ337503](DQ337503)\]    1400                        99.86
  *Flavobacterium mizutaii*                                                           (4 ReA + 6 UA + 2 OA + 1 RA)                              \[EMBL:[AJ438175](AJ438175)\]    1385                        94.00\*
  *Shigella*species                                                                   (5 ReA + 8 UA + 3 OA + 2 RA)                              \[EMBL:[DQ337523](DQ337523)\]    1399                        99.70
  *Stenotrophomonas maltophilia*                                                      (5 ReA + 8 UA + 3 OA + 1 RA)                              \[EMBL:[AJ293470](AJ293470)\]    1396                        99.75
  *Stenotrophomonas maltophilia*                                                      (5 ReA + 8 UA + 3 OA + 1 RA)                              \[EMBL:[AB294557](AB294557)\]    1396                        99.86
  **Bacteria not previously detected in arthritis but detected in human infection**                                                                                                                          
  ***Aranicola***species                                                              (4 ReA + 3 UA + 1 RA)                                     \[EMBL:[AM398227](AM398227)\]    1400                        99.64
  *Ralstonia*species                                                                  (3 ReA + 7 UA + 1 OA)                                     \[EMBL:[AB045276](AB045276)\]    1387                        99.86
  **Bacteria not previously detected in humans**                                                                                                                                                             
  ***Paenibacillus humicus***                                                         (4 ReA + 6 UA +1 OA + 1 RA)                               \[EMBL:[AM411528](AM411528)\]    1399                        98.60
  **Uncultured bacteria**                                                                                                                                                                                    
  Uncultured bacterium                                                                (4 ReA + 4 UA + 1 OA)                                     \[EMBL:[DQ818781](DQ818781)\]    1394                        98.90
  Uncultured bacterium                                                                (5 ReA + 4 UA + 2 OA + 2 RA)                              \[EMBL:[AY838480](AY838480)\]    1389                        94.00\*
  Uncultured bacterium                                                                (2 ReA + 3 UA + 1 OA + 2 RA)                              \[EMBL:[AB076874](AB076874)\]    1389                        94.00\*
  Uncultured bacterium                                                                (1 ReA +1 OA)                                             \[EMBL:[AY838458](AY838458)\]    1382                        99.64
  Uncultured bacterium                                                                (1 UA + 1 OA)                                             \[EMBL:[DQ824599](DQ824599)\]    1398                        99.57
  Uncultured β proteobacterium                                                        (4 ReA + 6 UA + 1 OA + 1 RA)                              \[EMBL:[DQ366010](DQ366010)\]    1384                        99.71
  Uncultured *Flavobacterium*species                                                  (3 ReA + 5 UA + 1 OA + 2 RA)                              \[EMBL:[DQ366085](DQ366085)\]    1300                        97.20
  Uncultured *Sphingobacterium*species                                                (1 ReA + 3 UA + 1 OA + 2 RA)                              \[EMBL:[AB076874](AB076874)\]    1389                        94.16\*

Number in brackets after species names indicate the number of patient set from whom bacteria were detected. ^a^Accession number of the bacterial species in the EMBL database. ^b^Length of alignment on which the 16S rDNA inserted sequence and the corresponding sequence in the database are similar. ^c^In the \'% similarity\' column, asterisks indicate highlight instances where the % similarity is below 97%. ^d^The \'Common bacteria\' row shows the bacteria identified in ReA, UA, RA, and OA patients.

Bacterial species detected only in SF samples and not in ST samples from our previous study \[[@B15]\], are indicated in bold.

OA = osteoarthritis; RA = rheumatoid arthritis; ReA = reactive arthritis; SF = synovial fluid; UA = undifferentiated arthritis.

Bacterial 16S rDNA sequences identified in synovial fluid samples
-----------------------------------------------------------------

Each patient\'s SF samples contained a diverse range of bacterial DNA-related species (Table [2](#T2){ref-type="table"}). The majority of pathogens across all groups were identified as *Shigella*species and *Stenotrophomonas maltophilia*. DNA from a total of 69 various individual bacterial species were detected in SF samples from ReA and UA patients, whereas only 10 different bacterial DNA were found in SF samples from RA and OA patients. In addition, DNA from 20 bacterial species was detected in both the study and the control groups.

In ReA and UA patients, apart from *Shigella sonnei*DNA, there was no other DNA-derived bacteria so far described to trigger ReA. There were sequences from commensal bacteria, in particular those from the skin or the intestinal tract (*Propionibacterium acnes*, *Escherichia coli*, and other coliform bacteria). We also detected additional species previously assigned to the *Pseudomonas*genus such as DNA of *Pseudomonas poae*, *Delftia acidovorans*, and *Burkholderia cepacia*. A detailed sequence analysis of the PCR-positive samples of ReA and UA patients revealed a number of DNA of bacteria that have previously been described in human infections but not in arthritis, including *Rhizobium radiobacter*, *Pantoea ananatis*, and *Capnocytophaga sputigena*. Except for *P. ananatis*, these DNA sequences were observed in only one individual (Table [3](#T3){ref-type="table"})

DNA products from environmental bacteria previously detected in arthritis, such as *Achromobacter xylosoxidans*, *Alcaligenes faecalis*, and *Flavobacterium mizutaii*were commonly found in both the study and control groups. DNA of *Aranicola*species bacterium rarely described in humans but not associated with arthritis was common in patients with ReA, UA, and RA and was detected in more than one case (Table [3](#T3){ref-type="table"}).

Some clones fell into environmental species not previously reported in human infections including DNA of *Paenibacillus humicus*, *Bacillus niacini*, and *Diaphorobacter*species, and other bacteria, which have not yet been cultured (Table [3](#T3){ref-type="table"}).

DNA from the candidate division OP10 bacterium was detected in SF samples of only two patients with UA. These bacterial DNA sequences have not been previously characterized by rDNA sequencing because they exhibit less than 97% similarity to known database sequences. We could find no clear association between the presence of a particular bacterial DNA and clinical symptoms.

Discussion
==========

In the present study we used broad-range PCR amplification, cloning, and sequencing of the full-length 16S rDNA from a wide variety of bacterial species in the SF samples of all patients studied. Only a few studies have been conducted to detect and identify the bacterial DNA communities in SF samples of patients with ReA, UA, and others arthropathies. In these studies, only short fragments of DNA were amplified allowing solely the determination of the bacterial genus but not the identification of the species level. This is, to our knowledge, the first study using the full-length 16S rRNA gene as a target for broad-spectrum PCR to detect bacterial DNA in SF samples allowing the identification of the species level.

Sequence analysis of the PCR-positive samples revealed the presence of a wide spectrum of bacterial DNA in SF samples of all studied patients. False positivity due to contamination poses a problem when broad-range PCR targeting the 16S rRNA is used \[[@B20]-[@B22]\]. However, our recently published study outlines extensive measures, which were also taken in the present study in order to avoid any contamination \[[@B15]\]. From a practical point of view, it is important to notice that we did not surgically incise the skin at the site of the aspiration thus avoiding contamination by the skin flora but our results are rather similar to those obtained by others who took this precaution \[[@B14]\]. PCR and extraction controls consistently yielded negative results indicating that the PCR products detected in positive samples are most likely derived from the bacterial rRNA genes actually present in SF cells. In addition, the sequences obtained varied between patients and DNA from several organisms has also been identified in arthritic human joints in independent laboratories \[[@B12]-[@B14],[@B17],[@B18]\], suggesting that their presence is unlikely to be a consequence of contamination.

The most common sequences of species found in SF samples of all patients (e.g. *A. xylosoxidans*, *A. faecalis, F. mizutaii*, and *S. maltophilia*) were also seen in the previous study \[[@B15]\], except the DNA from *Aranicola*species implying that they might be opportunistic colonizers of inflamed joints. *S. maltophilia*DNA was identified most frequently. This organism is an opportunistic pathogen and has previously been detected in arthritic knee joints \[[@B12],[@B15],[@B17]\]. Of note, other bacterial DNA have been described in human infections but not so far in arthritis were identified in the SF samples of our arthritic patients. Some of them are detected only in SF samples but not in their matched ST samples, such as *R. radiobacter*and *Pantoae ananatis*. Recently, we reported that DNA derived from uncultured bacteria and from environmental organisms that have not been previously detected in human samples could also be demonstrated in ST samples \[[@B15]\]. Similarly, in SF samples such bacterial DNA was detected including *Aminobacter aminovorans, B. niacini, Diaphorobacter*species, and uncultured candidate division OP10 bacterium. Several studies have also detected unsuspected uncultured and/or cultured bacteria not considered as human pathogens in arthritic joints but they were found by sequencing short DNA fragments \[[@B12]-[@B14],[@B16]\]. Thus, the identification of such bacterial species after cloning and near-full length 16S DNA sequencing might be of interest and should be pursued. However, their presence in the joint can not provide definite evidence of their replication or a functional role in arthritis.

Our results also confirmed the presence of *E. coli*sequences in SF samples as previously found in ST samples of arthritis patients \[[@B15]\]. This could indicate the ability of *E. coli*DNA to colonize inflamed joints; the gut in different patients would be expected to contain a material derived from a range of *E. coli*\'subspecies\' \[[@B23]-[@B25]\].

Our analysis of SF samples and their matched ST samples confirmed a wide spectrum of bacterial DNA-related species detected in each individual patient. Accordingly, a significant correlation was found between the diversity of bacterial species detected in SF and matched ST at the patient level (r = 0.522, *P*= 0.018). However, they revealed a different profile in regard to their known potential of triggering ReA in either SF or ST samples. Thus, the *Shigella flexneri*sequences were not detected in any of the SF samples whereas *S. sonnei*16 rDNA sequences were detected more frequently in SF samples of five ReA and five UA patients as compared with the ST samples of one ReA and one UA patient \[[@B15]\]. DNA of *Shigella*species was also prevalent in SF samples as demonstrated previously in ST samples \[[@B15]\], but it was more frequently detected in SF samples (five ReA, eight UA, two RA, and three OA in SF vs two ReA, four UA, two RA, and one OA in ST samples). Although *S. sonnei*and *Shigella*species were detected more frequently in SF than in ST samples, the difference was statistically not significant.

We detected DNA from *Shigella*species in our cohort of patients with various forms of arthritis and *S. sonnei*, known to trigger ReA, only in ReA and UA samples. *Shigella*DNA positive patients had no clinical signs of previous intestinal infection with an enteric organism. These patients may have been asymptomatic, or the preceding gastrointestinal symptoms may have been mild and overlooked by the patients \[[@B3]\]. It is possible that enteric organisms may migrate from asymptomatic primary sites of the infection to the synovial compartment \[[@B3]\]. Most *Shigella*ReA caused by *S. sonnei*are sporadic cases \[[@B26]\]. The most recent published case of *S. sonnei*related ReA was attributed to sexual transmission of the pathogen \[[@B27]\]. In our study, we detected *S. sonnei*DNA in five ReA patients presenting with an urogenital infection, which is consistent with the possibility that this species could be related to sexual transmission.

A composition of a mixture of bacterial nucleic acids was common in our cohort of patients with various forms of arthritis, as has been described in previous studies \[[@B13]-[@B15],[@B17],[@B18]\]. The bacterial DNA might be incorporated by macrophages, which are disseminated by the circulation and reach the joint due to an increased cellular recruitment. As opposed to a single organism, such mixtures may increase the risk of triggering an immune response finally culminating in synovitis. However, genetic susceptibility factors of the host are also playing an important role particularly in persistent infections \[[@B10],[@B28]\]. As mixtures of bacterial nucleic acids are also detectable in the SF samples from patients with RA and OA, we cannot exclude that this may represent a normal \'background\' phenomenon not necessarily causing synovitis \[[@B10],[@B17]\]. Another limitation of our study lies in the fact that we could not detect *Chlamydia trachomatis*DNA or other common bacteria known to trigger posturethritic arthritis.

Conclusions
===========

Our study provides a valuable overall picture of the bacterial DNA environment present in the SF of the actively inflamed joints of arthritis patients. Characterization of the DNA reveals a wide spectrum of organisms so far not known to be present in human infections, not known to be present in inflamed joints of arthritis patients, and not known to trigger ReA. There is also a differential bacterial colonisation and/or infection of SF and ST samples because the analysis of SF can identify a number of bacterial DNA-related species, which have not been detected in ST samples as studied earlier \[[@B15]\] and has helped to confirm that the composition of bacterial DNA may change over time in joint cavity.

Accordingly, the analysis of SF or ST samples from different arthropathies patients by broad-range PCR is essentially capable of characterising the bacterial DNA environment present in joint cavity. As synovial biopsy is a difficult act, SF is well practical for such purpose.
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